54
Views
5
CrossRef citations to date
0
Altmetric
Case Report

Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review

, , , , , , & show all
Pages 67-72 | Published online: 20 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tan Yang, Jianfang Feng, Qian Zhang, Wei Wu, Hailan Mo, Lanzhen Huang & Wei Zhang. (2020) l-Carnitine conjugated chitosan-stearic acid polymeric micelles for improving the oral bioavailability of paclitaxel. Drug Delivery 27:1, pages 575-584.
Read now

Articles from other publishers (4)

L. Qu, J. H. Wang, J. X. Du, P. Kang, X. Q. Niu & L. Z. Yin. (2021) Use of nimotuzumab combined with cisplatin in treatment of nasopharyngeal carcinoma and its effect on expressions of VEGF and MMP-2. Clinical and Translational Oncology 23:7, pages 1342-1349.
Crossref
Jin-Seok Choi, Nam Hyuk Cho, Dong-Hyun Kim & Jeong-Sook Park. (2019) Comparison of paclitaxel solid dispersion and polymeric micelles for improved oral bioavailability and in vitro anti-cancer effects. Materials Science and Engineering: C 100, pages 247-259.
Crossref
Qinghai LinHuige WangXinqiang LinWenrui ZhangShuhua HuangYandan Zheng. (2018) PTPN12 Affects Nasopharyngeal Carcinoma Cell Proliferation and Migration Through Regulating EGFR. Cancer Biotherapy and Radiopharmaceuticals 33:2, pages 60-64.
Crossref
. (2017) Cisplatin/fluorouracil/paclitaxel. Reactions Weekly 1645:1, pages 91-91.
Crossref